Weekly Recap | Vertex Pharma this week, closing in on record highsWeekly Review·Oct 3, 2026 at 08:01 AMVRTX+0.66%
Weekly Recap | Vertex Pharma +3.51%, kidney data in focusWeekly Review·Sep 26, 2026 at 07:17 AMVRTX+0.66%
Weekly Recap | Vertex Pharma -1.38%, consensus target above spotWeekly Review·Sep 19, 2026 at 06:59 AMVRTX+0.66%
Weekly Recap | Vertex Pharma -5.62%, low-volume pullback lags the S&P 500Weekly Review·Sep 12, 2026 at 07:06 AMVRTX+0.66%
Weekly Recap | Vertex Pharma +0.82%, closing in on record highsWeekly Review·Sep 5, 2026 at 08:25 AMVRTX+0.66%
Weekly Recap | Vertex Pharma -1.16%, most brokers rate it buyWeekly Review·Aug 29, 2026 at 06:39 AMVRTX+0.66%
Weekly Recap | Vertex Pharma +8.36%, crushing the S&P 500Weekly Review·Aug 22, 2026 at 05:55 AMVRTX+0.66%
